Multicentre, open-label post-marketing follow-up observational study to evaluate the efficacy/tolerability of the Philips BlueTouch Pain Relief Patch in the daily routine treatment of back pain - BlueTouch PRP 2013/14

Philips Consumer Lifestyle0 个研究点目标入组 1,000 人开始时间: 2014年3月25日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Patient age =18 years
•Patient is able and willing to understand a written informed consent
•Patient suffers from back pain
•Patient is able to comply with the study characteristics and to fulfill its requirements, according to the investigator's evaluation

•Patient is currently or was within the previous 4 weeks enrolled in an interventional clinical trial
•Patient is actually suffering from conditions and illnesses that might interfere with the trial purpose, according to the investigator's evaluation
•Patient has a history of substance abuse (drug or alcohol) or any other factor (e.g., serious psychiatric condition) that could limit the subject's ability to comply with trial procedures
•Patient has insufficient knowledge of the German language to understand the Informed Consent Form and/or trial questionnaires
•Patient is/was involved in the planning and conduct of the trial (applies to either Philips staff, staff participating at the trial site or staff of the logistics CRO)
•Patient suffers from any condition or illness as listed in the contraindications section of the BlueTouch Pain Relief Patch user manual
•Patient has used the Philips BlueTouch Pain Relief Patch before

发起方